Cargando…
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
BACKGROUND AND OBJECTIVE: Whether pemetrexed plus platinum (PP) regimen is superior to gemcitabine plus platinum (GP) regimen for patients with advanced non-small cell lung cancer (NSCLC) is unclear. The aim of this study is to evaluate the efcacy and safety of PP versus GP regimens for patients wit...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999694/ https://www.ncbi.nlm.nih.gov/pubmed/21219831 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.09 |
Ejemplares similares
-
培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、对照、多中心临床研究
Publicado: (2012) -
吉西他滨单药/或联合铂类与紫杉类单药/或联合铂类不同顺序治疗晚期肺鳞癌的疗效与安全性
Publicado: (2015) -
培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
Publicado: (2012) -
HER2基因状态与晚期肺腺癌患者一线培美曲塞联合铂类化疗疗效的关系
Publicado: (2019) -
培美曲塞单药或联合铂类三线及以上治疗晚期非鳞型非小细胞肺癌的临床观察
Publicado: (2012)